Overview

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
Phase:
Phase 4
Details
Lead Sponsor:
Upsher-Smith Laboratories